Samsung Bioepis
Incheon · Founded 2012
About Samsung Bioepis
Samsung Bioepis Co., Ltd. develops and produces biopharmaceutical and biosimilar products. Samsung Bioepis Co., Ltd. has a strategic collaboration agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2012 and is based in Incheon,
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $1M – $10M
- Total funding: $667.5M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2018)
- Website: samsungbioepis.com
- Phone: +82 - 32 - 455 - 6114
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/samsung-bioepis-110518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.